￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Treatment methods and suggestions when side effects of Asinib/Asiminib occur

2026-02-01 22:25:32

Check Details
Instructions on the contraindications for the use of ritexitinib (Lefenox) and which groups should use it with caution

2026-02-01 22:25:32

Check Details
Sparsentan (sparsentan) onset of action time and treatment course evaluation recommendations

2026-02-01 22:25:32

Check Details
Whether ixazomib (Enleri) needs to be combined with other drug treatments and protocol recommendations

2026-02-01 22:25:32

Check Details
Is there any foreign generic drug and price reference for Lurbinectedin?

2026-02-01 22:25:32

Check Details
Pimitespib storage methods and daily drug management points

2026-02-01 22:25:32

Check Details
Afatinib (Gitarel) Phase III clinical trial results and data interpretation

2026-02-01 22:25:32

Check Details
Drug safety analysis and long-term use risk assessment of DaliRasheng (Keweike)

2026-02-01 22:25:32

Check Details
Detailed explanation of Olaparib specifications, dosage and price information

2026-02-01 22:25:32

Check Details
Venetoclax/Venetoclax adverse reaction treatment methods and clinical emergency measures

2026-02-01 22:25:32

Check Details
Is it necessary to take long-term use of Asnib/Asiminib (Sinbel) and its medication strategy?

2026-02-01 22:25:32

Check Details
Analysis of discontinuation methods and safe discontinuation strategies of ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Category
相关知识